ID

14536

Description

Tandem Autologous- Nonmyeloablative Allogeneic Transplant for Newly Diagnosed Multiple Myeloma (Trapianto Tandem Autologo-Allogenico Non Mieloablativo Nel Mieloma Alla Diagnosi); ODM derived from: https://clinicaltrials.gov/show/NCT00702247

Link

https://clinicaltrials.gov/show/NCT00702247

Keywords

  1. 4/19/16 4/19/16 -
Uploaded on

April 19, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Multiple Myeloma NCT00702247

Eligibility Multiple Myeloma NCT00702247

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
durie-salmon stage iia-iiib multiple myeloma
Description

Durie-salmon stage

Data type

boolean

Alias
UMLS CUI [1]
C0278723
UMLS CUI [2]
C0278724
age > 18 and ≤ 65 years
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
previously untreated myeloma
Description

Untreated myeloma

Data type

boolean

Alias
UMLS CUI [1,1]
C0026764
UMLS CUI [1,2]
C0332155
presence of a sibling (potential donor)
Description

Sibling

Data type

boolean

Alias
UMLS CUI [1]
C0037047
bilirubins < twice normal;alat and asat < four times normal
Description

Bilirubin, alat and asat

Data type

boolean

Alias
UMLS CUI [1]
C1278039
UMLS CUI [2]
C0201836
UMLS CUI [3]
C0201899
left ventricular ejection fraction > 40%
Description

Left ventricular ejection fraction

Data type

boolean

Alias
UMLS CUI [1]
C0428772
creatinine clearances > 40 ml/min
Description

Creatinine clearance

Data type

boolean

Alias
UMLS CUI [1]
C0373595
pulmonary dysfunction with diffusing capacity for carbon monoxide (dlco) > 40% and/or need for continuous oxygen supplementation
Description

Dlco, continuous oxygen supplementation

Data type

boolean

Alias
UMLS CUI [1]
C1516251
UMLS CUI [2]
C4039841
karnofsky performance status > 60%
Description

Karnofsky performance status

Data type

boolean

Alias
UMLS CUI [1]
C0206065
patients must give written informed consent
Description

Informed consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
age > 65 years
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
previously treated myeloma
Description

Treated myeloma

Data type

boolean

Alias
UMLS CUI [1,1]
C0026764
UMLS CUI [1,2]
C0332154
absence of a sibling (genetic randomisation cannot be applied)
Description

Sibling

Data type

boolean

Alias
UMLS CUI [1]
C0037047
karnofsky performance status score < 60%
Description

Karnofsky performance status

Data type

boolean

Alias
UMLS CUI [1]
C0206065
hiv-infection
Description

HIV-infection

Data type

boolean

Alias
UMLS CUI [1]
C0019693
pregnancy
Description

Pregnancy

Data type

boolean

Alias
UMLS CUI [1]
C0032961
refusal to use contraceptive techniques during and for 12 months following treatment
Description

Contraception

Data type

boolean

Alias
UMLS CUI [1]
C0700589
patients unable to give written informed consent
Description

Unable to informed consent

Data type

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C1299582
ps. informed consent is obtained from each patient according to the institutional review boards of the participating centers. the study is conducted according to the declaration of helsinki.
Description

Informed consent: specification

Data type

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C2348235

Similar models

Eligibility Multiple Myeloma NCT00702247

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Durie-salmon stage
Item
durie-salmon stage iia-iiib multiple myeloma
boolean
C0278723 (UMLS CUI [1])
C0278724 (UMLS CUI [2])
Age
Item
age > 18 and ≤ 65 years
boolean
C0001779 (UMLS CUI [1])
Untreated myeloma
Item
previously untreated myeloma
boolean
C0026764 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
Sibling
Item
presence of a sibling (potential donor)
boolean
C0037047 (UMLS CUI [1])
Bilirubin, alat and asat
Item
bilirubins < twice normal;alat and asat < four times normal
boolean
C1278039 (UMLS CUI [1])
C0201836 (UMLS CUI [2])
C0201899 (UMLS CUI [3])
Left ventricular ejection fraction
Item
left ventricular ejection fraction > 40%
boolean
C0428772 (UMLS CUI [1])
Creatinine clearance
Item
creatinine clearances > 40 ml/min
boolean
C0373595 (UMLS CUI [1])
Dlco, continuous oxygen supplementation
Item
pulmonary dysfunction with diffusing capacity for carbon monoxide (dlco) > 40% and/or need for continuous oxygen supplementation
boolean
C1516251 (UMLS CUI [1])
C4039841 (UMLS CUI [2])
Karnofsky performance status
Item
karnofsky performance status > 60%
boolean
C0206065 (UMLS CUI [1])
Informed consent
Item
patients must give written informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Age
Item
age > 65 years
boolean
C0001779 (UMLS CUI [1])
Treated myeloma
Item
previously treated myeloma
boolean
C0026764 (UMLS CUI [1,1])
C0332154 (UMLS CUI [1,2])
Sibling
Item
absence of a sibling (genetic randomisation cannot be applied)
boolean
C0037047 (UMLS CUI [1])
Karnofsky performance status
Item
karnofsky performance status score < 60%
boolean
C0206065 (UMLS CUI [1])
HIV-infection
Item
hiv-infection
boolean
C0019693 (UMLS CUI [1])
Pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])
Contraception
Item
refusal to use contraceptive techniques during and for 12 months following treatment
boolean
C0700589 (UMLS CUI [1])
Unable to informed consent
Item
patients unable to give written informed consent
boolean
C0021430 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
Informed consent: specification
Item
ps. informed consent is obtained from each patient according to the institutional review boards of the participating centers. the study is conducted according to the declaration of helsinki.
boolean
C0021430 (UMLS CUI [1,1])
C2348235 (UMLS CUI [1,2])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial